Cargando…
Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia
PURPOSE: Tardive dyskinesia (TD) is a common but serious hyperkinetic movement disorder and side effect of antipsychotic medications used to treat bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SZ). The purpose of this study was to evaluate health-related quality of life...
Autores principales: | McEvoy, Joseph, Gandhi, Sanjay K., Rizio, Avery A., Maher, Stephen, Kosinski, Mark, Bjorner, Jakob Bue, Carroll, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863950/ https://www.ncbi.nlm.nih.gov/pubmed/31435866 http://dx.doi.org/10.1007/s11136-019-02269-8 |
Ejemplares similares
-
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020) -
Genome wide study of tardive dyskinesia in schizophrenia
por: Lim, Keane, et al.
Publicado: (2021) -
Divalproex sodium leading to sustained significant improvement in tardive dyskinesia in a patient with bipolar disorder
por: Pattanayak, Raman Deep, et al.
Publicado: (2016) -
Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
por: Fedorenko, Olga Yu., et al.
Publicado: (2022) -
METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983)